Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
about
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationRecent progress in metabolic signaling pathways regulating aging and life spanCircadian rhythms and metabolic syndrome: from experimental genetics to human disease.Interactions of the circadian CLOCK system and the HPA axisNocturnal light exposure alters hepatic Pai-1 expression by stimulating the adrenal pathway in C3H mice.Circadian clock circuitry in colorectal cancer.PAI-1 in tissue fibrosis.The circadian clock and the hypoxic response pathway in kidney cancer.Interaction of circadian and stress systems in the regulation of adipose physiology.Circadian Clocks in the Hematologic System.Physiology and pathophysiology of the plasminogen system in the kidney.ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice.Circadian fluctuations in circulating plasminogen activator inhibitor-1 are independent of feeding cycles in mice.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.Early genetic responses in rat vascular tissue after simulated diving.Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease
P2860
Q26765455-E57B7E65-ACFC-4BF3-BD4E-C3190E232A59Q30415902-7B03F2FF-3789-4244-B37F-51BD8C859A6AQ33616159-7C2D6635-E73C-46AC-8E3E-5EAF985D2AF2Q33722806-8BFE2159-72C9-4261-89E1-69C069DC5C0BQ33823325-D762B330-B7D4-46E1-ACD4-2A92C1A12724Q34389831-A95F8F0A-A218-47C9-A168-12A44F913292Q37708008-0DAB1AE2-1202-4817-9FF4-57899807FA8EQ37861626-211996F3-4991-4B32-9136-7735E2576BAFQ38128792-B02FED41-71E1-43E5-9D53-F148F5CC3811Q38267494-7470E2FB-D385-439B-B530-D98079C9808CQ38545148-B04D544D-6FC9-4C77-9E20-A2444F3AD78CQ39401678-DE6FABFE-BBD7-42B1-B6A2-E6C5AB675633Q39422383-3F6CDE85-3EEA-47C6-89A4-AF5EB3539520Q49292081-A3AC9C26-BFD2-40DC-8613-47A9F70F3177Q51033889-5B465023-DAA9-4690-B2FA-9C62DA2AAEDFQ51361802-F4E5820B-96F0-4ED0-A122-829B89362ABFQ52931257-8BED158A-FD2D-4F41-879F-24481C10B9DBQ54284660-C062F686-235E-417D-9151-86072DCF4B12Q58130010-101D8911-1E17-43BF-9C7E-9D0EBFE68887
P2860
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@en
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@nl
type
label
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@en
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@nl
prefLabel
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@en
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@nl
P2860
P1476
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
@en
P2093
Katsutaka Oishi
P2860
P304
P356
10.1080/10641960902822468
P577
2009-05-01T00:00:00Z